Fazio S - Search Results

1

Altered lipoprotein metabolism in transgenic mice expressing low levels of a human receptor-binding-defective apolipoprotein E variant.

Fazio S, Horie Y, Simonet WS, Weisgraber KH, Taylor JM, Rall SC Jr. Fazio S, et al. J Lipid Res. 1994 Mar;35(3):408-16. J Lipid Res. 1994. PMID: 8014576 Free article.

2

Synthesis and secretion of apolipoprotein E occur independently of synthesis and secretion of apolipoprotein B-containing lipoproteins in HepG2 cells.

Fazio S, Yao Z, McCarthy BJ, Rall SC Jr. Fazio S, et al. J Biol Chem. 1992 Apr 5;267(10):6941-5. J Biol Chem. 1992. PMID: 1551903 Free article.

3

The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.

Horie Y, Fazio S, Westerlund JR, Weisgraber KH, Rall SC Jr. Horie Y, et al. Among authors: fazio s. J Biol Chem. 1992 Jan 25;267(3):1962-8. J Biol Chem. 1992. PMID: 1730728 Free article.

4

The enhanced association of apolipoprotein E with apolipoprotein B-containing lipoproteins in serum-stimulated hepatocytes occurs intracellularly.

Fazio S, Yao Z. Fazio S, et al. Arterioscler Thromb Vasc Biol. 1995 May;15(5):593-600. doi: 10.1161/01.atv.15.5.593. Arterioscler Thromb Vasc Biol. 1995. PMID: 7749873

5

Co-expression of cholesteryl ester transfer protein and defective apolipoprotein E in transgenic mice alters plasma cholesterol distribution. Implications for the pathogenesis of type III hyperlipoproteinemia.

Fazio S, Marotti KR, Lee YL, Castle CK, Melchior GW, Rall SC Jr. Fazio S, et al. J Biol Chem. 1994 Dec 23;269(51):32368-72. J Biol Chem. 1994. PMID: 7798236 Free article.

6

Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).

Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley RW, Rall SC Jr. Fazio S, et al. Arterioscler Thromb. 1994 Nov;14(11):1873-9. doi: 10.1161/01.atv.14.11.1873. Arterioscler Thromb. 1994. PMID: 7947615

7

Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.

Ji ZS, Fazio S, Mahley RW. Ji ZS, et al. Among authors: fazio s. J Biol Chem. 1994 May 6;269(18):13421-8. J Biol Chem. 1994. PMID: 8175773 Free article.

8

Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture.

Ji ZS, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW. Ji ZS, et al. Among authors: fazio s. J Biol Chem. 1994 May 6;269(18):13429-36. J Biol Chem. 1994. PMID: 8175774 Free article.

9

Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.

Ji ZS, Fazio S, Lee YL, Mahley RW. Ji ZS, et al. Among authors: fazio s. J Biol Chem. 1994 Jan 28;269(4):2764-72. J Biol Chem. 1994. PMID: 8300609 Free article.

10

Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E.

Fazio S, Lee YL, Ji ZS, Rall SC Jr. Fazio S, et al. J Clin Invest. 1993 Sep;92(3):1497-503. doi: 10.1172/JCI116728. J Clin Invest. 1993. PMID: 8376602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

800 results

Search Page

Filters